Literature DB >> 12361618

Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures.

M J A van Luyn1, R A Tio, X J Gallego y van Seijen, J A Plantinga, L F M H de Leij, M J L DeJongste, P B van Wachem.   

Abstract

Patients with heart failure have, in spite of improved palliative therapies, bad prognosis. Cardiac tissue engineering by use of a temporary bioscaffold and cardiomyocytes may help to find answers for future treatments in heart failure. For that purpose two neonatal rat heart ventricular cell fractions were obtained after a gradient cell separation. Time related characteristics of Fractions I and II were established in two-dimensional (2-D) and three-dimensional (3-D) cell cultures. The 3-D cardiac constructs were obtained by use of a bovine type I collagen matrix after culturing either under static conditions or in the HARV bioreactor. With the 2-D cultures contracting cells were present after 1 day, and reached confluency from day 5 on and this was maintained up to 135 days. In Fraction-I some non-contracting cells were always noticed between the (in time in unison) contracting cells. Transmission electron microscopy (TEM) revealed that these mainly concerned fibroblasts. Differences in the expression of alpha-SM-1 actin and troponin-T were observed between the two fractions. In both fractions endothelial cells and macrophages were only sporadically observed. All through the 3-D matrix pendant-like single cell and clustered cell contractions were present after 1-2 days, resulting in time in unison contracting of cells with the collagen matrices. The whole event was faster with Fraction-I and was observed up to 3 weeks. At this time point clusters of troponin-T positive cells were found scattered through the collagen matrices. Additionally, TEM revealed healthy layers of connected cardiomyocytes with intercalated discs, in this case on and in between the collagen fibres. These findings provide evidence that in unison contracting structurally organized cell-matrix cardiac constructs can be engineered by use of co-cultures (neonatal cardiomyocytes and fibroblasts) and collagen matrices, which is very promising for the repair of larger scar areas of the myocardium. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361618     DOI: 10.1016/s0142-9612(02)00230-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues.

Authors:  Thomas Boudou; Wesley R Legant; Anbin Mu; Michael A Borochin; Nimalan Thavandiran; Milica Radisic; Peter W Zandstra; Jonathan A Epstein; Kenneth B Margulies; Christopher S Chen
Journal:  Tissue Eng Part A       Date:  2012-01-04       Impact factor: 3.845

Review 2.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

3.  A modular approach to cardiac tissue engineering.

Authors:  Brendan M Leung; Michael V Sefton
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

Review 4.  Challenges in tissue engineering.

Authors:  Yoshito Ikada
Journal:  J R Soc Interface       Date:  2006-10-22       Impact factor: 4.118

5.  Comparison of mRNA expression of transcriptional factors and intercalated disk constituent proteins between in vivo and cultured cardiomyocytes.

Authors:  Takao Nakamura; Zhonggang Feng; Tsubasa Honda; Yasutomo Nomura; Tatsuo Kitajima; Mitsuo Umezu
Journal:  J Artif Organs       Date:  2008-10-05       Impact factor: 1.731

Review 6.  Changing Metabolism in Differentiating Cardiac Progenitor Cells-Can Stem Cells Become Metabolically Flexible Cardiomyocytes?

Authors:  Sophia Malandraki-Miller; Colleen A Lopez; Heba Al-Siddiqi; Carolyn A Carr
Journal:  Front Cardiovasc Med       Date:  2018-09-19

Review 7.  Natural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution.

Authors:  Qasim A Majid; Annabelle T R Fricker; David A Gregory; Natalia Davidenko; Olivia Hernandez Cruz; Richard J Jabbour; Thomas J Owen; Pooja Basnett; Barbara Lukasiewicz; Molly Stevens; Serena Best; Ruth Cameron; Sanjay Sinha; Sian E Harding; Ipsita Roy
Journal:  Front Cardiovasc Med       Date:  2020-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.